Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO

• Status: Unknown status
• Trial end date: 2008-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Treatment of macular edema secondary to central retinal vein occlusion is more effective with combined therapy of bevacizumab and triamcinolone than bevacizumab alone.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Asociación para Evitar la Ceguera en México
• Treatments: Bevacizumab; Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide

Criteria

Inclusion Criteria:

• Macular edema secondary to central retinal vein occlusion

• BCVA worse than 20/40

• Central macular >250 mc with OCT

Exclusion Criteria:

• Diabetic retinopathy or other retinopathy

• Media opacity that does not allow following

• steroid responder

• diagnosed glaucoma or IOP > 21 mmHg